Nicola Dagg is excellent, a strategic thinker and a leader. She is well recognised in Europe and totally deserves it.” - Chambers UK, 2024
Nicola Dagg is a partner in the Intellectual Property Team in the London office of Kirkland & Ellis International LLP. Nicola’s practice spans four areas: (1) strategic patent and product lifecycle advice; (2) patent litigation; (3) coordinating global IP enforcement/defence cases; and (4) standard essential patent (SEP) and FRAND disputes.
Nicola has extensive experience on all aspects of intellectual property advisory and litigation work, including blockbuster small molecule litigation against generic companies, biologics and biosimilar litigation, antibodies, immunotherapies, genetics, vaccines, diagnostics and gene therapies. Nicola also acts in market leading SEP essentiality, validity and global FRAND adjudication litigation in the tech sector. Having served as UK and European/global coordinating counsel for numerous strategic IP projects litigation cases and drawing on almost 30 years of legal, IP, life sciences and tech experience she helps clients solve their most pressing global IP challenges.
Nicola is ranked as a leading Tier 1 IP partner in Chambers Global, Chambers UK, JUVE Patent and The Legal 500. Chambers UK 2024 recognises Nicola as a “top-notch leader” who is “extremely intelligent, thoughtful, creative and business-savvy.”
Nicola has consistently been recognised as a gold-ranked patent litigator by IAM Patent 1000 and in their 2023 directory they describe her as “a fearsome practitioner respected by all in the market… she delivers top quality strategic advice”.
The Legal 500 UK named Nicola a “Hall of Fame” attorney in the Intellectual Property Patents category, as well as a leading individual in Life Sciences and Healthcare. The 2024 edition refers to Nicola as “one of the outstanding patent litigators of current times.”
In addition, Nicola has repeatedly been named to Managing IP’s list of the “Top 250 Women in IP”.
Dagg, N., Lim, D., de Rohan-Truba, J., and Spiccia, N. (2023) “Life Sciences & Pharma IP Litigation 2023: Law and Practice”, Chambers and Partners Practice Guides
Dagg, N., Lim, D., Baldwin, S., and Bornstein, G. (2023) “Trade Secrets 2023: Law and Practice”, Chambers and Partners Practice Guides
Dagg, N., Lim, D., Baldwin, S., and Bornstein, G. (2022) “Trade Secrets 2022: Law and Practice”, Chambers and Partners Practice Guides
Dagg, N., Baldwin, S., Coltart, K., and Shandler, B. (2021) “Patent Litigation 2021: Trends and Developments”, Chambers and Partners Practice Guides
Dagg, N., Lim, D., Baldwin, S., and Bornstein, G. (2020) “Trade Secrets 2020: Law and Practice”, Chambers and Partners Practice Guides
Dagg, N., Lim, D., Shandler, B., and Kritharidis, A. (2020) “Patent Litigation 2020: Trends and Developments”, Chambers and Partners Practice Guides
Dagg, N., Coltart, K., Lim, D., and Ooi, J. (2019) “Patent Litigation 2019: Trends and Developments”, Chambers and Partners Practice Guides
Influential Women in IP. WIPR (1 May 2019)
Regulatory issues key for life sciences in Brexit debate. Life Sciences Review (25 August 2017)
Life Sciences Patent Network Europe, Life Sciences Review (20 December 2016)
Admissions & Qualifications
- 1996, Admitted to Practice as a Solicitor of England and Wales
- Solicitor Advocate, Higher Court (Civil Proceedings)
- Admitted to the Law Society of Ireland
- Newnham College, University of CambridgeM.A., Natural Sciences1991
- University of BristolDiploma in Intellectual Property Law and Practice1997